Volume 85 Issue 43 | pp. 34-38
Issue Date: October 22, 2007

Optimism Prevails For Fine Chemicals

Increased product outsourcing and busier plants make custom manufacturers feel more prosperous at CPhI
Department: Business

BETWEEN 2000 AND 2005, pharmaceutical outsourcing was going nowhere, and the fine chemicals business nearly came to a standstill. Developers withdrew many late-stage and marketed products, leaving only a trickle of new projects coming out of the drug development pipeline. To cut costs, some drug firms moved production inside, using their own plants to make a diminishing number of drug candidates. Custom chemical manufacturers were left with limited business, excess capacity, and low-cost competition emerging . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society